Cargando…
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
PURPOSE: Boosting dominant intra-prostatic lesions (DILs) has the potential to increase the therapeutic ratio in prostate cancer radiotherapy. In this study, employing 5-fraction stereotactic ablative radiotherapy (SABR) volumetric modulated arc therapy (VMAT) to deliver 40 Gy to the prostate clinic...
Autores principales: | Osman, Sarah O. S., Fairmichael, Ciaran, Whitten, Glenn, Lundy, Gavin S., Wesselman, Rachel, Wilson, Melissa LaBonte, Hounsell, Alan R., Prise, Kevin M., Irvine, Denise, McGarry, Conor K., Jain, Suneil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862253/ https://www.ncbi.nlm.nih.gov/pubmed/35193630 http://dx.doi.org/10.1186/s13014-022-02003-8 |
Ejemplares similares
-
Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
por: Osman, Sarah O. S., et al.
Publicado: (2019) -
Class solutions for SABR-VMAT for high-risk prostate cancer with and without elective nodal irradiation
por: Osman, Sarah O. S., et al.
Publicado: (2016) -
Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
por: Ahmad Khalil, Dalia, et al.
Publicado: (2022) -
Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life
por: Osman, Sarah O. S., et al.
Publicado: (2017) -
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
por: Lyons, Ciara A., et al.
Publicado: (2017)